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ABSTRACT
Introduction More than 17% of German children and 
adolescents have clinically relevant mental health 
problems (MHP). Typically, general paediatricians are 
often the first contact for children with MHP, and referrals 
to specialised care tend to be the standard approach. A 
statutory health insurance fund developed a programme 
for children with MHP (Health Coaching (HC)) aiming 
to offer targeted but low- threshold services. However, 
little is known about whether HC has the potential for 
optimising patient care. The aim of the PrimA- QuO study 
is to examine the effectiveness and the acceptance, 
barriers and facilitators of all stakeholders of this 
structured primary care programme for children affected 
by the most frequently encountered MHP in paediatric 
practice.
Methods and analysis In this mixed- methods approach, 
children (n=800; aged 0–17 years) with MHP meeting all 
inclusion criteria will be identified in the health insurance 
database according to International Classification of 
Diseases, 10th Revision diagnoses between 2018 
and 2019. The qualitative component uses a series of 
semistructured interviews with programme developers, 
paediatricians trained in HC, adolescents with MHP treated 
according to the programme guidelines and their parents. 
In addition, a prospective, pragmatic, parallel- group cohort 
study will be conducted using an online questionnaire to 
examine the effects of HC on health- related quality of life 
of affected children and their families as well as on change 
in MHP. Children treated according to the HC guidelines 
form the intervention group, whereas all others serve as 
controls. Primary data from the cohort study are linked 
to children’s health insurance claims data to calculate 
the costs of care as proxies for healthcare utilisation. The 
hypothesis is that HC is an effective and efficient primary 
care programme with the potential to improve patients’ 
and their families’ health outcomes.
Ethics and dissemination The study was approved by 
the Ethical Committee of Ludwig- Maximilians- Universität 
München. Grant number 01VSF16032 (funded by the 
German Innovationsfonds)
INTRODUCTION
More than 17% of German children and 
adolescents have clinically relevant mental 
health problems (MHP).1 Among these, 
developmental disorders (17%) followed 
by conduct disorders (CD) (11%) are the 
most frequent conditions, with considerable 
impact on daily life, functioning and partic-
ipation of the affected children and their 
parents.2
In Germany, general paediatricians are 
often the first contact for children with MHP 
during prescribed examinations.3 Typically, 
the primary care physician would perform 
an initial screening, initiate treatment and 
recommend referral to specialised centres in 
severe cases. However, due to time constraints 
in daily practice and potential training defi-
cits of the respective physician, MHP may not 
Strengths and limitations of this study
 ► This study is a promising approach because it fo-
cuses on office- based paediatricians offering eas-
ily accessible care for children with mental health 
problems.
 ► Another strength of this study is its mixed- methods 
design, while qualitative interviews will allow deeper 
insights into barriers and facilitators of programme 
implementation.
 ► An additional economic evaluation will increase 
transparency and assist policy decisions.
 ► A limitation of the study is that patients can only 
enter the programme it they are insurees of one 
specific health fund, so results may not be easily 
generalisable.
 ► However, searching the health insurance funds da-
tabase for eligible children and adolescents is an ef-
ficient recruitment strategy, and a large sample size 
will most probably be obtained.
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be addressed adequately.4 It has been noted that referrals 
to specialised care tend to be the standard approach, irre-
spective of the severity of the problems, causing bottle-
necks for those who need specialised care.5
The German healthcare system facilitates the estab-
lishment of medical programmes driven by the statutory 
health insurance system if there is potential for opti-
mising patient care. Against this background, a statutory 
health insurance fund (Betriebskrankenkassen (BKK(Be-
trieskrankenkassen) LV(Landesverband))) in collabora-
tion with a paediatricians’ network (‘PaedNetz Bayern’) 
developed a programme for children and adolescents 
with MHP in 2011 (Health Coaching (HC)). This 
programme is part of a more general preventive paedi-
atric care programme (BKK STARKE KIDS (SK)) that 
aims to improve, for example, early screening coverage 
and immunisation rates.
The aim of HC is to offer targeted but low- threshold 
services. It includes a training concept for paediatricians 
providing standardised and evidence- based guidelines 
for 16 mental health- specific conditions.6 Paediatricians 
certified by HC receive additional reimbursement and 
will thus be able to invest more time and attention. During 
the training, paediatricians gain knowledge in dealing 
with the standardised guidelines to diagnose children 
with MHP correctly. In addition, the training is supposed 
to empower paediatricians to decide on adequate treat-
ment options or refer children, if necessary, as soon as 
possible to the appropriate specialist care. By applying 
these direct stepped- care principles, HC has the potential 
to avoid overtreatment and medicalisation particularly 
for children with minor impairments, and at the same 
time, it should counteract the shortage in specialist care 
for more severe cases. As compensation for an extended 
consultation, paediatricians certified by this HC are paid 
an additional fee.
Uptake of HC including trainings for paediatricians 
started in 2013 in Bavaria and is currently only avail-
able for persons insured at the BKK funds. To decide 
whether HC should be maintained or even rolled out 
to other regions and for insurees of other health funds, 
the effectiveness of the programme and its barriers and 
facilitators have to be confirmed. In addition, an evalu-
ation may point at unmet needs of stakeholders as well 
as indicate whether and where modifications should be 
planned.
To evaluate effects, costs, facilitators and barriers of the 
programme, a mixed- methods study that integrates quali-
tative and quantitative design aspects was planned .
The aim of the study is to examine the effectiveness and 
the acceptance, barriers and facilitators of all stakeholders 
of a structured primary care programme for children and 
adolescents affected by the most frequently encountered 
MHP in paediatric practice.
Specifically, we want to examine the following:
1. The theoretical foundation and the achievement of 
anticipated targets of HC from the developer’s per-
spective of HC.
2. The acceptance, barriers and facilitators of HC on the 
levels of (a) primary paediatricians trained in HC, (b) 
children and adolescents treated according to HC and 
(c) guardians of affected children and adolescents, 
who are treated according to HC.
3. The effects HC has on (a) children’s health- related 
quality of life (HRQoL), (b) parenteral HRQoL and 
(c) MHP of children and adolescents treated accord-
ing to HC compared with children of the same diagno-
sis, who receive standard care.
4. The utilisation of health services of children and ado-
lescents treated according to HC compared with chil-
dren of the same diagnosis, who receive standard care. 
In addition, a cost- effectiveness analysis including chil-
dren’s HRQoL will be performed.
METHODS AND ANALYSIS
The mixed- methods approach allows us to answer two 
important research questions. The qualitative compo-
nent emphasises the acceptance of the programme 
among paediatricians and families, whereas the quantita-
tive component analyses whether HC has the potential to 
change HRQoL and MHP over time.
Qualitative methods
The qualitative component of this study aims to indicate 
potential strengths and challenges of HC. Therefore, it 
uses a series of semistructured interviews with the leading 
programme developers, paediatricians who are trained 
in HC, adolescents (≥14 years of age) with MHP treated 
according to the programme guidelines and parents 
of children (<14 years of age) with MHP also treated 
according to the programme guidelines.
Participants and data collection procedures
Paediatricians trained in HC will be chosen from the 
participating Bavarian paediatricians’ network (‘Paed-
Netz Bayern’; https://www. paednetz. de/ startseite/) and 
invited to participate. Over 80% of office- based paediatri-
cians in Bavaria are members of PaedNetz Bayern.
Adolescents (at least 14 years old) and parents of chil-
dren younger than 14 years will be asked to participate in 
qualitative interviews via the online questionnaire. Volun-
teers are then selected based on purposeful sampling, 
according to principles of maximum variance regarding, 
for example, diagnosis, age, social class and gender, by 
the interviewers.
All three leading HC developers have been recruited 
during a project meeting in May 2017 and have agreed 
to participate.
Sample size will be determined by saturation.7 Recruit-
ment will be stopped if no new themes emerge during 
the interviews. Saturation will be determined by mutual 
agreement.
Interviews are conducted via telephone starting in 
November 2017.
In preparation for the semistructured interviews, guide-
lines are constructed according to Helfferich8 to ensure 
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that important predetermined topics are covered. The 
subdivision into key questions, subquestions and checks 
ensures that the conversation is guided in a targeted 
manner and important topics are covered. Similarly, an 
open atmosphere is created for a narrative of one’s own 
experiences or an expression of individuals’ concerns. 
The interview guide can be developed further during the 
course of the study. There are no questions or advance 
information provided by the interviewers prior to the 
interview.
The final interview guideline including the age- 
appropriate version for adolescents is pretested with a 
selection of voluntary adults and adolescents to detect, 
for example, any problems of comprehension, difficulties 
with the sequence or phrasing of the questions, or the use 
of improper youth slang. After subjects gave an informed 
consent and permission for audio recording, the inter-
views started. Paediatricians, parents and children receive 
allowance and financial compensation for participation.
Research team and reflexivity
Interviews are conducted by project scientists (Master of 
Public Health) and those with formal training in quanti-
tative and qualitative research.
Analysis and findings
All interviews are transcribed verbatim and are inde-
pendently analysed by the authors (the first and second 
author). The transcripts are not returned to study partici-
pants for control or correction. On the basis of the inter-
view guideline, the structured content analysis approach 
derived from Mayering9 10 is applied. Following Mayering, 
a deductive and an inductive approach for coding is 
performed. This offers, on the one hand, a deductive 
allocation of statements from the interviews to categories 
and codes identified in advance. On the other hand, the 
inductive procedure enables to derive new categories and 
codes from the data and thereby extend the coding tree 
by statements, which cannot be appropriately assigned 
to one of the a priori defined categories or codes. In an 
ongoing reconciliation between the authors, the coding 
tree is refined by differentiating the added codes in a 
more meaningful way or by removing them.
Guiding questions in the programme developers’ inter-
views are the reflection of the key principles and the theo-
retical foundation of HC, regarding how its anticipated 
targets are already achieved in practice and request for 
further development.
Guiding questions in the paediatricians’ interviews 
are the challenges in the implementation of HC in daily 
practice routine, investigating successful and impractical 
aspects of HC from the users’ perspective.
Guiding questions in the children’s and parents’ inter-
views are their satisfaction with the medical care, their 
relationship to the paediatrician, the degree of partici-
pation in the paediatricians' decisions and the desire for 
further support and improvement.
Quantitative methods
To examine the effects of HC on HRQoL of affected chil-
dren and their families, a prospective cohort study will 
be conducted using an online questionnaire. To analyse 
health service utilisation, primary data from the cohort 
study are linked to children’s health insurance claims 
data from 2017 and 2018.
Participants and data collection procedures
Children and adolescents aged 0–17 years will be 
included if they are insured at the BKK funds and had 
been enrolled in the BKK SK programme; it means in 
effect that they benefit from enhanced screenings and 
had at least one consultation at an office- based paedia-
trician in Bavaria, Germany, during the last 6 months for 
developmental disorder of speech and language (SLD), 
non- organic enuresis (NE), head and abdominal pain, 
somatoform (Head and abdominal pain (HAP)) and 
conduct disorder (CD) (International Classification of 
Diseases, 10th Revision (ICD-10) diagnoses: SLD: F80.0–
F80.9; NE: F98.0; HAP: G44.2, G43.0, G43.1, R10.4, F45.4; 
CD: F68.8, F91.0–F92.9, F94.0–F95.9, F98.3–F98.9). 
Informed consent is elicited from legal guardians/parents 
and from children/adolescents aged 6 years or older. As 
this trial is performed in a real- world setting, allocation 
to the intervention group is formed if the child has been 
treated by a Health Coach, meaning that a paediatrician 
had underwent a specific training and is able to demon-
strably act according to the training concept and to use its 
standardised guidelines for actions (members of BKK, SK 
and HC). All others serve as controls (members of BKK 
and SK but not HC).
Parents of eligible children are contacted by mail and 
given a link to the online questionnaire. Access is regu-
lated by users’ authentication via their insurance number. 
For the follow- up survey, consenting parents are contacted 
again 12 months after their participation in the question-
naire. Parents receive a small compensation for participa-
tion. All procedures are designed in full compliance with 
European and national data protection legislation.11 12
For the linkage of survey data to routine data, a tempo-
rary pseudonym based on the participant’s insurance 
number will be provided.13 For purposes of verification, 
month and year of birth and sex are additionally trans-
mitted. Based on the temporary pseudonym, primary 
data will be linked to the routine data by a third indepen-
dent person providing a second pseudonym. The linkage 
process is monitored by a legal data protection officer 
who saves the list with the first and second pseudonym.
Measures—outcomes
The primary outcome is HRQoL of children. We will use 
the generic and validated German- language instrument 
KINDLR.14 It consists of 24 items divided between six 
dimensions (with four items each): physical well- being, 
emotional well- being, self- worth, well- being in the family, 
well- being related to friends/peers and school- related 
well- being. Each item provides answer on a five- point 
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Likert scale ranging from never, seldom, sometimes, 
often and always. The total score will be transformed into 
values between 0 and 100, where higher values indicate a 
better HRQoL. The child and adolescent self- assessment 
version is used for children aged 11 years or older; for 
younger children, the proxy version is to be completed 
by the parents.
Secondary outcomes are HRQoL of parents and 
MHP of children. HRQoL of parents is measured using 
the EuroQol Five- Dimensional Five- Level Questionnaire 
(EQ- 5D- 5L), including the Visual Analogue Scale (EQ- 
VAS) assessing self- rated health.15 16 It comprises five 
dimensions (with one five- point Likert- scaled item each): 
mobility, self- care, usual activities, pain/discomfort and 
anxiety/depression ranging from no problems (1) to 
extreme problems (5). The EQ- 5D- 5L utility score ranges 
between death (−0.661) and perfect health (1) and is 
calculated based on the value set devised by Ludwig et 
al.17 In the EQ- VAS, the self- rated health is visualised on a 
continuous VAS with end points labelled the worst imag-
inable health (0) and the best imaginable health (100).
MHP of children are measured using the German 
version of the Strengths and Difficulties Questionnaire.18–21 It 
consists of 25 items divided between five dimensions (with 
five items each): emotional symptoms, conduct problems, 
hyperactivity/inattention, peer- related problems and 
prosocial behaviour. Each item is scored on a three- point 
scale ranging from not true, somewhat true to certainly 
true. Higher scores indicate greater MHP except for the 
prosocial behaviour dimension, for which a higher score 
indicates more positive behaviour. The subscores of the 
problem dimensions will be summed up to build the 
total difficulties score ranging from 0 to 40, where higher 
values denote greater difficulties.22 The child and adoles-
cent self- assessment version is used for children aged 11 
years or older, whereas the proxy version is completed for 
younger children.
All outcomes are listed in table 1.
Measures—independent variables
In addition, sociodemographic data (for instance, age, 
sex, migrant background or educational level of the 
guardians) and health- related data (for instance diag-
nosis group) are assessed.
Indicators for health service utilisation
Costs of care are calculated as proxies for healthcare 
utilisation from a statutory health insurance perspec-
tive. Costs of care are included if the child receives a 
confirmed MHP diagnosis in the outpatient setting or a 
primary diagnosis during hospitalisation. Outpatient ICD 
diagnoses in Germany have to be categorised as ‘Z’=con-
dition after, ‘A’=exclusion diagnosis, ‘V’=suspected diag-
nosis and ‘G’=confirmed diagnosis.
We analyse (1) disease- related specialised care, (2) 
disease- related paediatrician care and (3) overall disease- 
related care separately. First, disease- related specialised 
care involves costs for specialised institution and for 
specialised outpatient physician and outpatient psycho-
therapist visits. Here, specialised institutions include 
outpatient hospital visits in social paediatric centres and 
university outpatient clinics as well as hospitalisations to 
psychiatric departments or institutions. Furthermore, 
specialised outpatient physician costs are included if the 
physician’s specialty or subspecialty was psychiatry or 
psychotherapy, while outpatient psychotherapist costs are 
calculated by accounting for visits to a psychotherapist.
Second, we calculate costs of disease- related paediatri-
cian care.
Third, we look at the overall disease- related care. Here, 
we include all costs of disease- related outpatient and 
inpatient care as well as pharmaceutical costs for MHP- 
related drugs (psycholeptics, psychoanaleptics) and 
MHP- related therapist costs (speech therapists, ergother-
apists, physiotherapists).
All expenditures are calculated on a per quarter base. 
While outpatient physician costs and costs for social 
paediatric centres and university outpatient clinics are 
already based on quarters, the other cost domains have to 
be transformed. Inpatient care refers to a specific period, 
with a possible overlap between quarters. Here, we calcu-
late the costs proportionally to time of service use. Drugs 
and therapist care are based on exact prescription dates. 
The costs of all prescriptions within a quarter are summed 
up to get per quarter values.
Statistical analysis
Regarding descriptive statistics, means and SD are used for 
continuous variables and absolute and relative percent-
ages for categorical variables. For comparisons between 
children and adolescents with MHP treated according to 
the HC guidelines and those who receive standard care 
bivariate, non- parametric and parametric tests stratified 
by sociodemographic and disease- related variables will be 
conducted at baseline.
The association of the dependent variable of change 
in children’s HRQoL over time with the HC intervention 
will be performed by generalised estimating equations 
(GEE)23 as the GEE model takes into account the correla-
tion between repeated measurements within the same 
subjects. It will be adjusted for sociodemographic factors 
and diagnosis group. Interactions with time/follow- up 
will be included to observe significant group differences 
in their changes in HRQoL.
In a similar way, we will investigate the associations 
between HC and change in outcomes in parental HRQoL 
and change in MHP.
To estimate the group differences in healthcare 
utilisation, we use generalised linear models24 with 
Gamma- distributed cost variables (ie, the responses are 
non- negative). In addition, a cost- effectiveness analysis 
including HRQoL might be performed.
Sample size considerations
The sample size for the cohort study is calculated based 
on the recommendations for the minimally important 
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differences in quality of life instruments to be half an SD.25 
Accordingly, an effect size of 0.5 for the difference and a 
sample size of 85 children and adolescents for each group 
of indication can be assumed. Considering a drop- out of 
15% between data collection waves, we have estimated an 
overall sample size of 800 individuals (control and inter-
vention arms with 400 each). The sample size allows a 
level of precision of ±3.4 of the mean- value estimation of 
the KINDLR per indication group (assumed SD of 16.0).
Patient and public involvement
Children and adolescents with MHP and their guardians 
participated in assessing the phrasing of the interview 
guide. There is no plan to involve participants in the 
recruitment process and in conducting the study. Results 
of the study will be disseminated via email contacts to 
guardians as well as via social and print media.
DISCUSSION
The study examines the effectiveness of a standardised 
primary care programme regarding its potential to 
impact HRQoL of children with MHP and their parents. 
Also, cost- effectiveness of the programme and potential 
for improvement will be investigated.
This programme is a promising approach because it 
focuses on the office- based paediatrician offering easily 
accessible care for children with MHP.26 One strength of 
the planned study is its mixed- methods design. Qualita-
tive interviews will allow deeper insights into the barriers 
and facilitators of programme implementation. An addi-
tional economic evaluation will increase transparency 
and assist policy decisions.
It has to be kept in mind that patients can only enter 
the programme it they are insurees of one specific health 
fund, so results may not be easily generalisable. However, 
we anticipate that the results of this evaluation will moti-
vate the design of similar programmes that strengthen 
the competence of primary care.
Ethics and dissemination
The PrimA- QuO study is conducted in accordance with 
the Declaration of Helsinki,27 standards of Good Epidemi-
ology Practice28 and current EU- General Data Protection 
Regulations.12 It was approved by the Ethical Committees 
of Ludwig- Maximilians- Universität München (approval 
number for the qualitative part: 17-431; approval number 
for the quantitative part: 17-497) and positively reviewed 
by the data protection officer of Ludwig- Maximilians- 
Universität München.
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